FAMOTIDINE TABLET

Krajina: Kanada

Jazyk: angličtina

Zdroj: Health Canada

Kúpte ho teraz

Aktívna zložka:

FAMOTIDINE

Dostupné z:

SANIS HEALTH INC

ATC kód:

A02BA03

INN (Medzinárodný Name):

FAMOTIDINE

Dávkovanie:

40MG

Forma lieku:

TABLET

Zloženie:

FAMOTIDINE 40MG

Spôsob podávania:

ORAL

Počet v balení:

100

Typ predpisu:

Prescription

Terapeutické oblasti:

HISTAMINE H2-ANTAGONISTS

Prehľad produktov:

Active ingredient group (AIG) number: 0118722002; AHFS:

Stav Autorizácia:

APPROVED

Dátum Autorizácia:

2023-04-19

Súhrn charakteristických

                                Page 1 of 30
PRODUCT MONOGRAPH
PR
FAMOTIDINE
Famotidine Tablets
20 mg and 40 mg
USP
Histamine H
2
Receptor Antagonist
Sanis Health Inc.
1 President's Choice Circle
Brampton, Ontario
L6Y 5S5
Date of Revision:
APR 19, 2023
Submission Control Number: 273498
Page 2 of 30
PRODUCT MONOGRAPH
Pr
FAMOTIDINE
Famotidine Tablets
20 mg and 40 mg
THERAPEUTIC CLASSIFICATION
Histamine H
2
Receptor Antagonist
ACTION AND CLINICAL PHARMACOLOGY
Famotidine is a competitive inhibitor of histamine H
2
receptors. The primary clinically
important pharmacologic activity of famotidine is inhibition of
gastric juice secretion.
Famotidine reduces the acid and pepsin content, as well as the volume,
of basal, nocturnal,
and stimulated gastric secretion.
COMPARATIVE BIOAVAILABILITY STUDIES
A single dose, two-way crossover comparative bioavailability study of
FAMOTIDINE 40
mg tablets (Sanis Health Inc.) with PEPCID
®
40 mg tablets (Merck, Sharp & Dohme,
Canada) was conducted in healthy, adult, male subjects under fasting
conditions.
Comparative bioavailability data from 24 subjects that were included
in the statistical
analysis are presented in the following table:
Page 3 of 30
SUMMARY TABLE OF THE COMPARATIVE BIOAVAILABILITY DATA
Famotidine
(1 x 40 mg)
Geometric Mean
Arithmetic Mean (CV%)
Parameter
Test
1
Reference
2
% Ratio of
Geometric Means
90% Confidence
Interval
AUC
T
(ng
·
h/mL)
760.0
804.4 (30)
691.5
751.1 (41)
110
98 - 124
AUC
I
(ng
·
h/mL)
811.9
858.6 (31)
749.2
828.9 (51)
108
96 - 122
C
max
(ng/mL)
133.9
142.0 (32)
121.3
127.0 (30)
110
99 - 123
T
max
3
(h)
2.4 (35)
2.6 (36)
T
1/2
3
(h)
4.09 (74)
4.26 (92)
1
FAMOTIDINE (famotidine) tablets, 40 mg (Sanis Health Inc.)
2
PEPCID
®
(famotidine) tablets, 40 mg (Merck, Sharp & Dohme, Canada)
3
Expressed as the arithmetic mean (CV%) only
A single dose, two-way crossover comparative bioavailability study of
FAMOTIDINE 20
mg tablets (Sanis Health Inc.) with PEPCID
®
20 mg tablets (Merck, Sharp & Dohme,
Canada) was conducted in healthy, adult, male subjects under fasting
conditions.
Comparat
                                
                                Prečítajte si celý dokument
                                
                            

Dokumenty v iných jazykoch

Súhrn charakteristických Súhrn charakteristických francúzština 19-04-2023

Vyhľadávajte upozornenia súvisiace s týmto produktom

Zobraziť históriu dokumentov